Literature DB >> 22609247

Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury.

Ying He1, Xuebi Tian, Xiaoyu Hu, Frank Porreca, Zaijie Jim Wang.   

Abstract

UNLABELLED: Patients with chronic pain experience spontaneous or ongoing pain as well as enhanced sensitivity to evoked stimuli. Spontaneous or ongoing pain is rarely evaluated in preclinical studies. In fact, it remains controversial whether ongoing or spontaneous pain even develops in mice after tissue or nerve injury. This study tested a hypothesis that negative reinforcement can be used to unmask the presence of pain in mice with tissue or nerve injury. We found that spinal administration of clonidine or lidocaine did not elicit conditioned place preference (CPP) in uninjured or sham-operated mice. However, these agents produced CPP in mice with chronic inflammation induced by complete Freund's adjuvant (CFA) or following L5/L6 spinal nerve ligation (SNL). These data indicate the presence of non-evoked (ie, stimulus-independent) ongoing pain in mice with chronic inflammation (CFA) or following nerve injury (SNL). In addition, this study validates the use of negative reinforcement to unmask non-evoked ongoing pain in mice. Given the existence of a large collection of transgenic and knockout mice, our data show the application of this approach to elucidate molecular mechanisms underlying non-evoked pain and to contribute to drug discovery for pain. PERSPECTIVE: We demonstrated the presence of non-evoked ongoing pain in mice with chronic inflammation or following nerve injury. The study also validates the use of negative reinforcement to unmask non-evoked pain in mice. We propose to apply this approach to identify molecular mechanisms and effective drugs for chronic pain.
Copyright © 2012 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22609247      PMCID: PMC3367085          DOI: 10.1016/j.jpain.2012.03.011

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  34 in total

1.  Coding of facial expressions of pain in the laboratory mouse.

Authors:  Dale J Langford; Andrea L Bailey; Mona Lisa Chanda; Sarah E Clarke; Tanya E Drummond; Stephanie Echols; Sarah Glick; Joelle Ingrao; Tammy Klassen-Ross; Michael L Lacroix-Fralish; Lynn Matsumiya; Robert E Sorge; Susana G Sotocinal; John M Tabaka; David Wong; Arn M J M van den Maagdenberg; Michel D Ferrari; Kenneth D Craig; Jeffrey S Mogil
Journal:  Nat Methods       Date:  2010-05-09       Impact factor: 28.547

2.  Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy.

Authors:  Marc Kerba; Jackson S Y Wu; Qiuli Duan; Neil A Hagen; Michael I Bennett
Journal:  J Clin Oncol       Date:  2010-10-04       Impact factor: 44.544

3.  Chronic pain management in cancer survivors.

Authors:  Natalie Moryl; Nessa Coyle; Samuel Essandoh; Paul Glare
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

4.  Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia.

Authors:  Yan Chen; Cheng Yang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

5.  Unmasking the tonic-aversive state in neuropathic pain.

Authors:  Tamara King; Louis Vera-Portocarrero; Tannia Gutierrez; Todd W Vanderah; Gregory Dussor; Josephine Lai; Howard L Fields; Frank Porreca
Journal:  Nat Neurosci       Date:  2009-09-27       Impact factor: 24.884

6.  Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord.

Authors:  Carolyn A Fairbanks; Kelley F Kitto; H Oanh Nguyen; Laura S Stone; George L Wilcox
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

7.  A robust automated system elucidates mouse home cage behavioral structure.

Authors:  Evan H Goulding; A Katrin Schenk; Punita Juneja; Adrienne W MacKay; Jennifer M Wade; Laurence H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

8.  Polyneuropathy, with and without neurogenic pain, and its impact on daily life activities--a descriptive study.

Authors:  Gunilla M Liedberg; Magnus Vrethem
Journal:  Disabil Rehabil       Date:  2009       Impact factor: 3.033

9.  Acute inhibition of Ca2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice.

Authors:  Yan Chen; Fang Luo; Cheng Yang; Chelsea M Kirkmire; Zaijie Jim Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-05-28       Impact factor: 4.030

10.  Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents.

Authors:  Alec Okun; Milena DeFelice; Nathan Eyde; Jiyang Ren; Ramon Mercado; Tamara King; Frank Porreca
Journal:  Mol Pain       Date:  2011-01-10       Impact factor: 3.395

View more
  41 in total

1.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

2.  Identifying the Role of Novel Protein Kinase C Isoforms in Mediating Paclitaxel-Induced Peripheral Neuropathy.

Authors:  Amanda L Blaker; Carmen M Mitchell; Erin A Semple
Journal:  J Neurosci       Date:  2015-07-15       Impact factor: 6.167

Review 3.  Reward and motivation in pain and pain relief.

Authors:  Edita Navratilova; Frank Porreca
Journal:  Nat Neurosci       Date:  2014-09-25       Impact factor: 24.884

4.  CaMKIIα Mediates the Effect of IL-17 To Promote Ongoing Spontaneous and Evoked Pain in Multiple Sclerosis.

Authors:  Xiaoyu Hu; Fang Huang; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2017-11-16       Impact factor: 6.167

5.  Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.

Authors:  Ying He; Zaijie Jim Wang
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

6.  Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence.

Authors:  G Corder; S Doolen; R R Donahue; M K Winter; B L Jutras; Y He; X Hu; J S Wieskopf; J S Mogil; D R Storm; Z J Wang; K E McCarson; B K Taylor
Journal:  Science       Date:  2013-09-20       Impact factor: 47.728

7.  The transcription factor C/EBPβ in the dorsal root ganglion contributes to peripheral nerve trauma-induced nociceptive hypersensitivity.

Authors:  Zhisong Li; Yuanyuan Mao; Lingli Liang; Shaogen Wu; Jingjing Yuan; Kai Mo; Weihua Cai; Qingxiang Mao; Jing Cao; Alex Bekker; Wei Zhang; Yuan-Xiang Tao
Journal:  Sci Signal       Date:  2017-07-11       Impact factor: 8.192

8.  Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.

Authors:  Ryan B Griggs; Renee R Donahue; Braxton G Adkins; Katie L Anderson; Olivier Thibault; Bradley K Taylor
Journal:  J Pain       Date:  2015-12-12       Impact factor: 5.820

9.  Assessment of avoidance behaviors in mouse models of muscle pain.

Authors:  D Pratt; P N Fuchs; K A Sluka
Journal:  Neuroscience       Date:  2013-06-07       Impact factor: 3.590

10.  PKCδ-targeted intervention relieves chronic pain in a murine sickle cell disease model.

Authors:  Ying He; Diana J Wilkie; Jonathan Nazari; Rui Wang; Robert O Messing; Joseph DeSimone; Robert E Molokie; Zaijie Jim Wang
Journal:  J Clin Invest       Date:  2016-06-27       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.